Tuesday, November 14, 2006

After DRL, its Spectrum to Settle Imitrex Patent Dispute with Glaxo

Spectrum Pharmaceutical has settled Imitrex patent litigation with GlaxoSmithKline relating to Sumatriptan injection. However, the terms of settlement are subject to government review which provides Spectrum to distribute authorized generic versions of Sumatriptan injection products in the U.S. With this, GSK continue to keep playing smarter!

No comments:

Post a Comment